tm logo
EMLEVTUS
Live/Pending
PUBLISHED FOR OPPOSITION

on 30 Apr 2024

Last Applicant/ Owned by

65, quai Georges Gorse

Boulogne-Billancourt

R

92100

Serial Number

97583734 filed on 08th Sep 2022

Registration Number

N/A

Correspondent Address

Ben NatterHAUG PARTNERS, LLP

745 ITH AVENUE

NEW YORK,NY

10151

UNITE STATES

Filing Basis

No Filing Basis

Disclaimer

NO DATA

EMLEVTUS

Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, cRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue disease, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospam, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations containing notably botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified components of the toxin haemagglutin complex for skin care and the treatment of neurological disorders

Mark Details


Serial Number

No 97583734

Mark Type

No Service/Collective Mark

Attorney Docket Number

No A968-31

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
30th Apr 2024OICIAL GAZETTE PUBLICATION CONIRMATION E-MAILE
30th Apr 2024PUBLISHE OR OPPOSITION
10th Apr 2024NOTIICATION O NOTICE O PUBLICATION E-MAILE
27th Mar 2024APPROVE OR PUB - PRINCIPAL REGISTER
27th Mar 2024EXAMINER'S AMENMENT ENTERE
27th Mar 2024NOTIICATION O EXAMINERS AMENMENT E-MAILE
27th Mar 2024EXAMINERS AMENMENT E-MAILE
27th Mar 2024EXAMINERS AMENMENT -WRITTEN
28th Feb 2024ASSIGNE TO EXAMINER
09th Feb 2024TEAS/EMAIL CORRESPONENCE ENTERE